Orna Therapeutics is partnering with Vertex Pharmaceuticals to develop gene-editing therapies for people with sickle cell disease (SCD) and transfusion-dependent beta-thalassemia ... SCD is caused by ...

This precision reduces the risk of unintended mutations and is particularly useful for correcting ... Casgevy is designed to treat sickle cell disease and transfusion-dependent beta-thalassemia. The ...

an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT is a severe genetic blood disorder where mutations in the beta-globin gene leads to reduced or ...

On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. Experts emphasized ...

an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT is a severe genetic blood disorder where mutations in the beta-globin gene leads to reduced or absence ...

Apple has released a new beta 3 update. Just hours after the recent debut of beta 3 for tvOS and HomePod only, watchOS 11.3 has received its beta 3 update too. New beta brings software updates clo ...

A new generation has arrived that will shape the world we know in the coming decades. Meet Gen Beta: anyone born between 2025 and 2039. They follow Generation Alpha, who are born between 2010 and ...

Apple released the first iOS 18.3 public beta back in mid-December before taking a holiday break. Now that the company is fully back to work, we should start seeing new betas more frequently.

Generation Beta is starting and entering into a world with AI, including the potential for ... [+] artificial general intelligence (AGI) and the vaunted artificial superintelligence (ASI).

This new year 2025 welcomes a new generation, known as Generation Beta. This cohort includes children born between January 1, 2025, and approximately 2039, succeeding Generation Alpha (2010-2024 ...